Study on the Efficacy and Safety of Gelaspan

NCT02808325 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypovolemia

Interventions

DRUG: Gelaspan 4%
DRUG: Gelofusine 4%

Sponsor

B. Braun Medical LLC